Binder profile
CHEMBL1732979
Bioactivity hit from ChEMBL on a similar protein.
Bound to: PA0552 — phosphoglycerate kinase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL1732979- UniProt (similar protein)
Q4GZG4- Target protein
- PA0552
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 308.3
- LogP ≤ 5 4.25
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 68.1
Matches PAINS filter: azo_A(324). May be a frequent false positive in HTS — review carefully.
Chemical representations
Canonical representations for cheminformatics workflows.
C=C(C)C(=O)Oc1ccc(N=Nc2ccc(C)cc2)ccc1=OC=C(C)C(=O)Oc1ccc(N=Nc2ccc(C)cc2)ccc1=O
InChI=1S/C18H16N2O3/c1-12(2)18(22)23-17-11-9-15(8-10-16(17)21)20-19-14-6-4-13(3)5-7-14/h4-11H,1H2,2-3H3InChI=1S/C18H16N2O3/c1-12(2)18(22)23-17-11-9-15(8-10-16(17)21)20-19-14-6-4-13(3)5-7-14/h4-11H,1H2,2-3H3
MRYNEXGYUVXVKV-UHFFFAOYSA-NMRYNEXGYUVXVKV-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Activity
- active
- Binding sites
- PF00162
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL1732979 →
- UniProt UniProt Q4GZG4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL1732979”) →
Other binders for this protein
Quick navigation to other ligands bound to PA0552.
PDB 4
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).